Home Streck Inc.

Streck Inc.

Streck Cell-Free DNA BCT® Earns U.S. FDA De Novo Clearance

"Streck is excited about this milestone for Cell-Free DNA BCT," said Product Manager Joel Lechner. "We have always known that Cell-Free DNA BCT is the best tube for customers who are concerned about pre-analytical variation, but De Novo IVD status solidifies Cell-Free DNA BCT as a truly novel collection tube."